首页> 外文期刊>Journal of chromatography, B. Analytical technologies in the biomedical and life sciences >Development and validation of a sensitive HPLC-ESI-MS/MS method for the direct determination of glucosamine in human plasma
【24h】

Development and validation of a sensitive HPLC-ESI-MS/MS method for the direct determination of glucosamine in human plasma

机译:直接测定人血浆中氨基葡萄糖的灵敏HPLC-ESI-MS / MS方法的开发和验证

获取原文
获取原文并翻译 | 示例
           

摘要

A sensitive and specific HPLC-ESI-MS/MS method for the direct determination of glucosamine in human plasma has been developed and validated. Plasma samples were analyzed after a simple, one-step protein precipitation clean-up with trichloroacetic acid using a polymer-based amino high-performance liquid chromatography (HPLC) column and a water/acetonitrile mobile phase elution gradient, with D-[1-C-13]glucosamine as the internal standard. Detection was performed by mass spectrometry, using an electrospray source and employing multiple reaction monitoring to separately monitor glucosamine and the internal standard. The limit of quantification of the method was 10 ng/ml of glucosamine and the calibration curve showed a good linearity up to 1000 ng/ml. The precision (R.S.D.) and the accuracy (bias) of the method at the limit of quantification were 13.8 and 4.0%, respectively, and the mean recovery of glucosamine at three concentration levels was 101.6 +/- 5.7%. The method was applied for the determination of glucosamine concentrations in human plasma samples collected from untreated healthy volunteers and, in a separate bioavailability study, to evaluate plasma glucosamine pharmacokinetics profiles after oral administration of crystalline glucosamine sulfate. (c) 2006 Elsevier B.V. All rights reserved.
机译:已经开发并验证了一种直接测定人血浆中氨基葡萄糖的灵敏且特异的HPLC-ESI-MS / MS方法。使用基于聚合物的氨基高效液相色谱(HPLC)色谱柱和水/乙腈流动相洗脱梯度,用D- [1- C-13]氨基葡萄糖为内标。通过质谱法进行检测,使用电喷雾源并采用多反应监测来分别监测葡糖胺和内标。该方法的定量限为10 ng / ml的葡萄糖胺,校准曲线显示高达1000 ng / ml的良好线性。该方法在定量极限时的精密度(R.S.D.)和准确度(bias)分别为13.8和4.0%,三种浓度水平下的氨基葡萄糖平均回收率为101.6 +/- 5.7%。该方法用于测定从未经治疗的健康志愿者收集的人血浆样品中的氨基葡萄糖浓度,并在一项单独的生物利用度研究中,用于评估口服硫酸葡萄糖胺结晶后血浆葡萄糖胺的药代动力学。 (c)2006 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号